Valuation: Dechra Pharmaceuticals

Market Cap 4.4B 5.89B 5.17B 4.79B 8.33B 564B 8.49B 57.04B 22.37B 277B 22.12B 21.64B 956B P/E 2022
64.8x
P/E 2023 -150x
Enterprise Value 4.83B 6.47B 5.67B 5.25B 9.14B 619B 9.32B 62.61B 24.56B 304B 24.28B 23.75B 1,050B EV / Sales 2022
5.8x
EV / Sales 2023 6.08x
Free-Float
-
Yield 2022
1.3%
Yield 2023 0.34%
3 years 3,644
Extreme 3644
3,868
5 years 2,473.32
Extreme 2473.323
5,525
10 years 1,171
Extreme 1171
5,525
Manager TitleAgeSince
Chief Executive Officer - 2024-06-09
Director of Finance/CFO 46 2019-04-02
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 46 2019-10-29
Director/Board Member 68 2016-11-30
Director/Board Member 59 2019-01-31
Date Insider Type Main position Quantity % Market Cap.
24-01-14Free

Chief Financial Officer

2,293 0.0020%
24-01-14Free

Chief Executive Officer

5,372 0.0047%
24-01-14Free

Chief Executive Officer

18,551 0.0163%

Financials

2022 2023
Net sales 682M 912M 800M 741M 1.29B 87.3B 1.31B 8.83B 3.46B 42.87B 3.43B 3.35B 148B 762M 1.02B 894M 828M 1.44B 97.51B 1.47B 9.86B 3.87B 47.89B 3.83B 3.74B 165B
Net income 58.2M 77.86M 68.29M 63.25M 110M 7.45B 112M 754M 296M 3.66B 292M 286M 12.64B -27.9M -37.33M -32.74M -30.32M -52.77M -3.57B -53.8M -361M -142M -1.75B -140M -137M -6.06B
Net Debt 208M 279M 244M 226M 394M 26.66B 401M 2.7B 1.06B 13.09B 1.05B 1.02B 45.21B 430M 575M 505M 467M 814M 55.07B 829M 5.57B 2.19B 27.05B 2.16B 2.11B 93.4B
Logo Dechra Pharmaceuticals
Dechra Pharmaceuticals PLC specializes in the manufacturing and marketing of veterinary pharmaceutical products. Net sales break down by family of products as follows: - companion animal products (74.6%); - food producing animal products (11.5%); - equine health products (7.3%); - animal feeds (5.1%); - other (1.5%): products manufactured by third parties. Net sales are distributed geographically as follows: the United Kingdom (8.5%), Germany (9.2%), Europe (31.2%), the United States (37.9%) and other (13.2%).
Employees
-
Sector
-